Crossmark

Study protocol: multimodal physiotherapy as an add-on treatment to botulinum neurotoxin type A therapy for patients with cervical dystonia: DysPT-multi—a prospective, multicentre, single-blind, randomized, controlled study

Crossref DOI link: https://doi.org/10.1186/s13063-021-05705-8

Published Online: 2021-10-25

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Werner, Christian

Loudovici-Krug, Dana https://orcid.org/0000-0002-3538-234X
Derlien, Steffen

Rakers, Florian

Smolenski, Ulrich C.

Lehmann, Thomas

Best, Norman

Günther, Albrecht
Funding

Funding for this research was provided by:

Ipsen Pharma (A-DE-52120-262)

Friedrich-Schiller-Universität Jena
License Information

Text and Data Mining valid from 2021-10-25

Version of Record valid from 2021-10-25
More Information

Article History

Received: 9 April 2021

Accepted: 8 October 2021

First Online: 25 October 2021

Declarations

:

: Ethics approval by Ethics Committee of the University Hospital Jena (reference number: 2019-1600_1-BO). Written, informed consent to participate will be obtained from all participants.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below